GSK plc

GSK plc Dividend

The Dividend of GSK plc (GSK.L) as of Nov 2, 2026 is 0.64 GBP. In the previous year, Dividend was 0.31 GBP — a change of 106.45% (higher).

Dividend

0.64GBP

YoY

106.45%

Dividend yield

4.55 %

Last updated:

How much dividend does GSK plc 2026 pay?

According to the latest status from November 2026, GSK plc paid a total of 0.64 GBP per share in dividends within the last 12 months. With the current GSK plc price of 18.45 GBP, this corresponds to a dividend yield of - %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 4.55%. The payout ratio is around 46% of earnings. The dividend has grown at 1.8% per year over the past 19 years.

Historical GSK plc Dividends

A dividend is paid times per year. Last year, the payout months were March, March, June, September and December.

Historical GSK plc Dividends
PaydateDividend
0.17GBP
0.17GBP
0.18GBP
0.16GBP
0.16GBP
0.16GBP
0.20GBP
0.16GBP
0.15GBP
0.15GBP
0.15GBP
0.16GBP
0.14GBP
0.14GBP
0.14GBP
0.14GBP
0.14GBP
0.16GBP
0.18GBP
0.29GBP
0.24GBP
0.24GBP
0.24GBP
0.29GBP
0.24GBP
0.24GBP
0.24GBP
0.29GBP
0.24GBP
0.24GBP
0.24GBP
0.29GBP
0.24GBP
0.24GBP
0.24GBP
0.29GBP
0.24GBP
0.24GBP
0.24GBP
0.29GBP
0.24GBP
0.24GBP
0.24GBP
0.54GBP
0.24GBP
0.24GBP
0.24GBP
0.29GBP
0.24GBP
0.24GBP
0.24GBP
0.29GBP
0.24GBP
0.23GBP
0.23GBP
0.28GBP
0.23GBP
0.21GBP
0.21GBP
0.33GBP
0.21GBP
0.20GBP
0.20GBP
0.24GBP
0.20GBP
0.19GBP
0.19GBP
0.23GBP
0.19GBP
0.18GBP
0.18GBP
0.21GBP
0.18GBP
0.16GBP
0.16GBP
0.20GBP
0.16GBP
0.15GBP
0.15GBP
0.18GBP
0.15GBP
0.14GBP
0.14GBP
0.18GBP
0.13GBP
0.13GBP
0.13GBP
0.15GBP
0.13GBP
0.13GBP
0.13GBP
0.18GBP
0.11GBP
0.11GBP
0.11GBP
0.16GBP
0.11GBP
0.11GBP
0.11GBP
0.15GBP
0.11GBP
0.11GBP
0.11GBP
0.29GBP
0.19GBP
0.28GBP
0.19GBP
0.26GBP
0.19GBP
0.25GBP
0.19GBP
0.24GBP
0.19GBP
0.19GBP
0.31GBP
0.00GBP
0.13GBP
0.28GBP
0.14GBP
0.11GBP
0.23GBP
0.11GBP
0.18GBP
0.10GBP
0.16GBP
0.07GBP
0.13GBP
0.06GBP

The GSK plc Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2024
0.31 GBP
Jan 1, 2025
0.64 GBP
Jan 1, 2026 (e)
0.34 GBP
Jan 1, 2027 (e)
0.68 GBP
Jan 1, 2028 (e)
0.68 GBP
Jan 1, 2029 (e)
0.68 GBP
Jan 1, 2030 (e)
0.68 GBP
Jan 1, 2031 (e)
0.68 GBP
The GSK plc Dividend history
YEARDividendYoY
est0.68GBP0.00%
est0.68GBP0.00%
est0.68GBP0.00%
est0.68GBP0.00%
est0.68GBP+100.00%
est0.34GBP-46.88%
0.64GBP+106.45%
0.31GBP-44.39%
0.56GBP-26.89%
0.76GBP-23.75%
1.00GBP0.00%
1.00GBP0.00%
1.00GBP0.00%
1.00GBP0.00%
1.00GBP-20.00%
1.25GBP+25.00%
1.00GBP0.00%
1.00GBP+3.90%
0.96GBP-1.28%
0.98GBP+14.71%
0.85GBP+6.25%
0.80GBP+6.67%
0.75GBP+7.14%
0.70GBP+9.80%
0.64GBP+6.25%
0.60GBP—

GSK plc dividend history and estimates

In 2025, GSK plc paid a dividend amounting to 0.84 GBP. Dividend means that GSK plc distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.00 GBP
0.00 GBP
Jan 1, 2022 (e)
0.76 GBP
-0.20 GBP
Jan 1, 2023
0.56 GBP
0.00 GBP
Jan 1, 2024
0.61 GBP
0.00 GBP
Jan 1, 2025 (e)
0.00 GBP
0.84 GBP
Jan 1, 2026 (e)
0.34 GBP
0.34 GBP
Jan 1, 2027 (e)
0.00 GBP
0.68 GBP
Jan 1, 2028 (e)
0.00 GBP
0.68 GBP

Is the GSK plc Dividend Safe?

GSK plc has been increasing the dividend for 2 years.

Over the past 10 years, GSK plc has lowered it by an annual -1.73%.

Over a five-year period, the distribution dropped by -3.43%.

Analysts expect a Dividend Cut of -10.03% for the current fiscal year.

GSK plc dividend payout ratio

In 2025, GSK plc had a payout ratio of 45.75%. The payout ratio indicates the percentage of the company's profits that GSK plc distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
74.02 %
Jan 1, 2022
20.86 %
Jan 1, 2023
46.58 %
Jan 1, 2024
49.90 %
Jan 1, 2025
45.75 %
Jan 1, 2026 (e)
37.99 %
Jan 1, 2027 (e)
36.28 %
Jan 1, 2028 (e)
34.58 %

Dividend Details

Understanding GSK plc's Dividend Distributions

GSK plc’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining GSK plc's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

GSK plc's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in GSK plc’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

GSK plc Stock analysis

What does GSK plc do? GSK plc generates revenue through its Pharmaceuticals and Vaccines segments, which focus on developing and selling prescription medicines and vaccines. The Pharmaceuticals segment offers products in Respiratory, HIV, Specialty, and Classic and Established categories, targeting acute and chronic diseases. The Vaccines segment provides over 40 vaccines for pediatric, adolescent, adult, and older populations, including travel vaccines. Customers include healthcare providers, hospitals, and consumers purchasing over-the-counter products. GSK's brand portfolio spans prescription medicines like those for Respiratory and HIV, alongside vaccines such as those for pediatric and adult health. The company's research focuses on six therapeutic areas: Respiratory diseases, HIV/infectious diseases, Vaccines, Immuno-inflammation, Oncology, and Rare diseases. This research drives product development for both segments, ensuring a steady pipeline of medicines and vaccines. The company's products are distributed globally, with the Pharmaceuticals business targeting healthcare professionals and the Vaccines business serving public health programs and individual consumers. GSK's strategy emphasizes innovation in key therapeutic areas to address unmet medical needs, leveraging its extensive research and development capabilities to maintain market leadership. GSK plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GSK plc stock

Over the past 12 months, GSK plc paid a dividend of 0.84 GBP . This corresponds to a dividend yield of about 4.55 %. For the coming 12 months, GSK plc is expected to pay a dividend of 0.68 GBP.

The current dividend yield of GSK plc is 4.55 %.

GSK plc pays a dividend, distributed in the months of November, February, May, August.

GSK plc paid dividends every year for the past 36 years.

For the upcoming 12 months, dividends amounting to 0.68 GBP are expected. This corresponds to a dividend yield of 3.69 %.

GSK plc is assigned to the 'Health' sector.

In the year 2025, GSK plc distributed 0.84 GBP as dividends.

The dividends of GSK plc are distributed in GBP.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — GSK plc